ISSCR

Listen to our innovation showcase, view our posters or pop by our booth!

Come and visit our team at our stand #1002 to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.

Innovation Showcase: Thursday 11 July | 12pm-1pm

Don't miss our innovation showcase talk on "Unlocking the power of deterministic cell programming in biomedical research and drug discovery"in Hall G2, Level 2 | 12pm – 1pm | Thursday, 11 July.

Speakers: Matthias Pawlowski (University of Münster), Sejla Salic-Hainzl (bit.bio) and Tony Oosterveen, Prinicpal Scientist (bit.bio). 

Grab a pretzel and a coffee and listen to our speakers!

Poster Presentations: Wednesday 11 July | 5.45pm-7.45pm

We will be presenting the following posters on a wide range of our ioCells including ioMicroglia & associated Disease Models, ioSensory Neurons, ioSkeletal Myocytes disease models, CRISPR-Ready Glutamatergic Neurons and CRISPR ioMicroglia:

• PHYSIOLOGICALLY RELEVANT MEDIA UNMASKS SEVERE MITOCHONDRIAL DYSFUNCTION IN A PRECISION REPROGRAMMED IPSC-DERIVED MODEL OF HUNTINGTON'S DISEASE
  Presented by: Tony Oosterveen | Principal Scientist | bit.bio
  Presentation date: Wednesday July 10
  Poster board number: 502
  Poster Presentation time: 6:45 PM - 7:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

• GENERATION AND FUNCTIONAL CHARACTERISATION OF MOTOR NEURONS DERIVED THROUGH TRANSCRIPTION FACTOR MEDIATED PROGRAMMING OF HUMAN PLURIPOTENT STEM CELLS
  Presented by:  Tom Brown | Senior Product Manager | bit.bio
  Presentation date: Wednesday July 10
  Poster board number: 521
  Poster Presentation time: 5:45 PM - 6:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

• A TOOLBOX OF HUMAN IPSC-DERIVED MICROGLIA IN DIFFERENT GENETIC BACKGROUNDS AND DISEASE MODELS FOR NEURODEGENERATION DRUG DISCOVERY
  Presented by: Ann Byrne | Business Development Manager, Functional Genomics | bit.bio
  Presentation date: Wednesday July 10
  Poster board number: 378
  Poster Presentation time: 6:45 PM - 7:45 PM
  Track: Disease Modelling and Drug Discovery (DMD)

• SCALABLE IPSC PROGRAMMING STRATEGY IN COMBINATION WITH OPTIMISED COCKTAILS OF NEUROTROPHIC FACTORS YIELDS FUNCTIONALLY DISTINCT NOCICEPTOR SENSORY NEURONS
  Presented by: Roisin Nicoll | Senior Account Manager | bit.bio
  Presentation date: Wednesday July 10
  Poster board number: 525
  Poster Presentation time: 5:45 PM - 6:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

• HARNESSING CRISPR-READY GLUTAMATERGIC NEURONS FOR DRUG DISCOVERY IN NEURODEGENERATIVE DISEASES
  Presented by: Lisa Grabner | Project Lead | bit.bio Discovery
  Presentation date: Wednesday July 10
  Poster board number: 513
  Poster Presentation time: 5:45 PM - 6:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

• ADVANCING DRUG DISCOVERY: LEVERAGING CRISPR-READY MICROGLIA FOR FUNCTIONAL GENOMICS STUDIES
  Presented by: Clara Schmidt | Senior Scientist | bit.bio Discovery
  Presentation date: Wednesday July 10
  Poster board number: 309
  Poster Presentation time: 5:45 PM - : 6:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

• SCALABLE AND WELL DEFINED HUMAN GLUTAMATERGIC AND GABAERGIC CO CULTURE PLATFORM SUITABLE FOR STUDYING EXCITATORY INHIBITORY NEURON IMBALANCES AND THE DISCOVERY OF DRUGS TO TREAT ASSOCIATED DISEASES
  Presented by: Antoinette Krainz | Senior Account Manager | bit.bio
  Presentation date: Wednesday July 10, 2024
  Poster board number: 505
  Poster Presentation time: 5:45 PM - 6:45 PM
  Track: Disease Modelling and Drug Discovery (DMDD)

Focus Session: Friday 12 July | 8.15am-9.45am

In this focus session, hosted by Blue Rock Therapeutics, bit.bio's Mark Kotter will join experts from Evotec, University Medical Center Göttingen, Memorial Sloan Kettering Cancer Center, and Blue Rock Therapeutics 'Realising the potential of PSC-derived therapies from research to clinical translation'.

Mark will share success stories and retrospective learnings that have helped to overcome hurdles in manufacturing human cells consistently at scale.

Panel Discussion: Friday 12 July | 1.30pm-3pm

Mark Kotter will participate in a panel 'Use of standards for stem cells in non-clinical research' the panel will be discussing standard implementation alongside a broad international forum of researchers, including major names from Leiden University, Jackson Laboratories, NIBSC and NIH.

We look forward to seeing you there!